Long-term adherence to antimuscarinic therapy in everyday practice: A systematic review

Journal of Urology

Volumn 191, Issue 4, 2014, Pages 1003-1008

  Veenboer, Paul W ^a   Bosch, J L H Ruud ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

cholinergic antagonists; medication adherence; muscarinic antagonists; patient compliance; urinary incontinence

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN;

ABSENCE OF SIDE EFFECTS; ARTICLE; DRUG DATABASE; DRUG FORMULATION; DRUG RELEASE; EMBASE; HUMAN; MEDICATION COMPLIANCE; MEDLINE; OVERACTIVE BLADDER; PRIORITY JOURNAL; RISK FACTOR; SELF REPORT; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URINALYSIS; URINE INCONTINENCE; AGE; CLINICAL PRACTICE; CONTROLLED RELEASE FORMULATION; FEAR; GENERAL PRACTITIONER; GYNECOLOGIST; HEALTH INSURANCE; HEALTH SURVEY; IMMEDIATE RELEASE FORMULATION; LONG TERM CARE; METHODOLOGY; PATIENT COMPLIANCE; PRESCRIPTION; TELEPHONE INTERVIEW;

CHOLINERGIC ANTAGONISTS; MEDICATION ADHERENCE; MUSCARINIC ANTAGONISTS; PATIENT COMPLIANCE; URINARY INCONTINENCE;

HUMANS; MEDICATION ADHERENCE; MUSCARINIC ANTAGONISTS; TIME FACTORS; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 84898492627     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.10.046     Document Type: Article

References (21)

1. J.A. Cramer, A. Roy, and A. Burrell et al. Medication compliance and persistence: terminology and definitions Value Health 11 2008 44
2. C.C. Sexton, S.M. Notte, and C. Maroulis et al. Persistence and adherence in the treatment of overactive bladder syndrome with anticholinergic therapy: a systematic review of the literature Int J Clin Pract 65 2011 567
3. PRISMA: Transparent Reporting of Systematic Reviews and Meta-analyses. Available at www.prisma-statement.org/. Accessed August 16, 2013.
4. National Institute for Health and Care Excellence: CG40 Urinary incontinence: search strategies. Available at www.nice.org.uk. Accessed January 25, 2011.
5. B. Vrijens, S. De Geest, and D.A. Hughes et al. A new taxonomy for describing and defining adherence to medications Br J Clin Pharmacol 73 2012 691
6. P.M. Ho, C.L. Bryson, and J.S. Rumsfeld Medication adherence: its importance in cardiovascular outcomes Circulation 119 2009 3028
7. R. Balkrishnan, M.J. Bhosle, and F.T. Camacho et al. Predictors of medication adherence and associated health care costs in an older population with overactive bladder syndrome: a longitudinal cohort study J Urol 175 2006 1067
8. J.S. Benner, M.B. Nichol, and E.S. Rovner et al. Patient-reported reasons for discontinuing overactive bladder medication BJU Int 105 2010 1276
9. L. Brubaker, K. Fanning, and E.L. Goldberg et al. Predictors of discontinuing overactive bladder medications BJU Int 105 2010 1283
10. A.O. D'Souza, M.J. Smith, and L.A. Miller et al. Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan J Manag Care Pharm 14 2008 291
11. T. Gomes, D.N. Juurlink, and M.M. Mamdani Comparative adherence to oxybutynin or tolterodine among older patients Eur J Clin Pharmacol 68 2012 97
12. M. Gopal, K. Haynes, and S.L. Bellamy et al. Discontinuation rates of anticholinergic medications used for the treatment of lower urinary tract symptoms Obstet Gynecol 112 2008 1311
13. S. Johnston, S.W. Janning, and G.P. Haas et al. Comparative persistence and adherence to overactive bladder medications in patients with and without diabetes Int J Clin Pract 66 2012 1042
14. K. Jundt, K. Schreyer, and K. Friese et al. Anticholinergic therapy: do the patients take the pills prescribed? Arch Gynecol Obstet 284 2011 663
15. C.L. Sears, C. Lewis, and K. Noel et al. Overactive bladder medication adherence when medication is free to patients J Urol 183 2010 1077
16. F.T. Shaya, S. Blume, and A. Gu et al. Persistence with overactive bladder pharmacotherapy in a Medicaid population Am J Manag Care, suppl 11 2005 S121
17. A. Wagg, G. Compion, and A. Fahey et al. Persistence with prescribed antimuscarinic therapy for overactive bladder: a UK experience BJU Int 110 2012 1767
18. J. Yeaw, J.S. Benner, and J.G. Walt et al. Comparing adherence and persistence across 6 chronic medication classes J Manag Care Pharm 15 2009 728
19. Y.F. Yu, M.B. Nichol, and A.P. Yu et al. Persistence and adherence of medications for chronic overactive bladder/urinary incontinence in the California Medicaid program Value Health 8 2005 495
20. S. Brostrom, and J. Hallas Persistence of antimuscarinic drug use Eur J Clin Pharmacol 65 2009 309
21. R.K. Basra, A. Wagg, and C. Chapple et al. A review of adherence to drug therapy in patients with overactive bladder BJU Int 102 2008 774